
Aurinia Pharmaceuticals AUPH
$ 16.44
0.33%
Aurinia Pharmaceuticals Historical Prices | AUPH
Annual Historical Prices Aurinia Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13.8 | 7.55 | 6.1 | 9.1 | 12.3 | 14 | 17.5 | 6.75 | 5.21 | 3.56 | 2.37 | 4.7 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 17.5 | 2.37 | 8.58 |
Historical Prices of other stocks in the Biotechnology industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AnaptysBio
ANAB
|
54.9 | $ 51.0 | 1.83 % | $ 1.48 B | ||
|
Allakos
ALLK
|
1.31 | - | - | $ 28.6 M | ||
|
Black Diamond Therapeutics
BDTX
|
2.19 | $ 1.88 | 0.53 % | $ 107 M | ||
|
Clovis Oncology
CLVS
|
2.04 | - | -7.23 % | $ 13 M | ||
|
Concert Pharmaceuticals
CNCE
|
3.03 | - | - | $ 401 M | ||
|
Evelo Biosciences
EVLO
|
0.31 | - | -14.46 % | $ 27.9 M | ||
|
BioMarin Pharmaceutical
BMRN
|
61 | $ 60.26 | 0.06 % | $ 11.6 B | ||
|
BioNTech SE
BNTX
|
91.2 | $ 98.52 | 0.24 % | $ 23.8 B | ||
|
Can-Fite BioPharma Ltd.
CANF
|
2.92 | $ 2.17 | 0.46 % | $ 3.57 M | ||
|
Freeline Therapeutics Holdings plc
FRLN
|
4.4 | - | - | $ 384 M | ||
|
Genocea Biosciences
GNCA
|
1.06 | - | -15.0 % | $ 3.04 M | ||
|
Catalyst Biosciences
CBIO
|
11.2 | $ 13.99 | 0.84 % | $ 1.25 B | ||
|
C4 Therapeutics
CCCC
|
2.82 | $ 2.98 | 0.3 % | $ 247 M | ||
|
Codexis
CDXS
|
1.27 | $ 1.32 | 1.09 % | $ 115 M | ||
|
Amryt Pharma plc
AMYT
|
10.8 | - | - | $ 621 M | ||
|
Cerus Corporation
CERS
|
2.6 | $ 2.62 | 0.38 % | $ 499 M | ||
|
G1 Therapeutics
GTHX
|
3.35 | - | - | $ 370 M | ||
|
Coherus BioSciences
CHRS
|
1.93 | $ 1.13 | 0.43 % | $ 132 M | ||
|
Celldex Therapeutics
CLDX
|
30.7 | $ 31.1 | 1.16 % | $ 2.07 B | ||
|
CollPlant Biotechnologies Ltd.
CLGN
|
0.38 | $ 4.25 | 3.16 % | $ 51.9 M | ||
|
Cellectar Biosciences
CLRB
|
2.87 | $ 1.8 | 0.72 % | $ 4.69 M | ||
|
AbbVie
ABBV
|
226 | $ 264.34 | 0.09 % | $ 468 B | ||
|
Humanigen
HGEN
|
0.14 | - | -81.12 % | $ 4.28 M | ||
|
Cocrystal Pharma
COCP
|
1.01 | $ 1.17 | 1.74 % | $ 13.2 M | ||
|
AbCellera Biologics
ABCL
|
3.22 | $ 12.7 | 0.4 % | $ 3.79 B | ||
|
Abeona Therapeutics
ABEO
|
4.76 | $ 5.4 | 2.65 % | $ 286 M | ||
|
Collegium Pharmaceutical
COLL
|
44.2 | $ 22.53 | 0.2 % | $ 713 M | ||
|
Corcept Therapeutics Incorporated
CORT
|
36.1 | $ 116.1 | 4.93 % | $ 12.1 B | ||
|
IGM Biosciences
IGMS
|
1.4 | - | - | $ 76.9 M | ||
|
IMV
IMV
|
0.82 | - | - | $ 13.1 M | ||
|
Kinnate Biopharma
KNTE
|
2.66 | - | - | $ 123 M | ||
|
Cardiff Oncology
CRDF
|
1.74 | $ 1.24 | 0.74 % | $ 82.9 M | ||
|
Checkmate Pharmaceuticals
CMPI
|
2.44 | - | - | $ 231 M | ||
|
Corbus Pharmaceuticals Holdings
CRBP
|
9.55 | $ 7.14 | 0.19 % | $ 95.1 M | ||
|
Karuna Therapeutics
KRTX
|
319 | - | - | $ 12.2 B | ||
|
Curis
CRIS
|
0.72 | $ 0.83 | 1.1 % | $ 10.9 M | ||
|
CorMedix
CRMD
|
6.33 | $ 7.85 | 1.03 % | $ 565 K | ||
|
Crinetics Pharmaceuticals
CRNX
|
43.7 | $ 84.95 | 0.13 % | $ 7.99 B | ||
|
CRISPR Therapeutics AG
CRSP
|
48.8 | $ 54.23 | 0.23 % | $ 4.88 B | ||
|
Champions Oncology
CSBR
|
6.06 | $ 4.9 | 0.1 % | $ 67.8 M | ||
|
Chimerix
CMRX
|
1.17 | - | - | $ 756 M | ||
|
Corvus Pharmaceuticals
CRVS
|
4.03 | $ 11.62 | 8.21 % | $ 918 M | ||
|
Cue Biopharma
CUE
|
0.31 | $ 31.41 | 1.45 % | $ 2.98 B | ||
|
CEL-SCI Corporation
CVM
|
2.48 | $ 1.67 | 2.38 % | $ 13.4 M | ||
|
Arbutus Biopharma Corporation
ABUS
|
4.42 | $ 4.85 | 0.2 % | $ 929 M | ||
|
Cytokinetics, Incorporated
CYTK
|
62.8 | $ 64.66 | 0.17 % | $ 7.77 M | ||
|
Daré Bioscience
DARE
|
1.51 | $ 0.78 | 4.73 % | $ 8.72 M | ||
|
Adagene
ADAG
|
3.8 | $ 2.93 | 2.86 % | $ 173 M | ||
|
DiaMedica Therapeutics
DMAC
|
6.64 | $ 7.94 | 1.4 % | $ 373 M |